Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.

Cytokine - 1 Jul 2006

Sfar Sana, Hassen Elham, Saad Hamadi, Mosbah Faouzi, Chouchane Lotfi

Abstract excerpt

OBJECTIVES: Vascular endothelial growth factor (VEGF) is a potent stimulus of angiogenesis that has an important role in many human malignancies including prostate carcinoma (PCa). We evaluated the role of the functional VEGF polymorphisms as genetic markers for PCa susceptibility and prognosis. METHODS: The study included 101 patients with PCa and [corrected] 100 age-matched healthy men. The VEGF genotypes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Haplotypes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Predictive Value of Tests

Share to Prostatic Neoplasms

Share to Risk Factors

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 16908180
DOI: 10.1016/j.cyto.2006.07.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.PMID 16908180Read ↗

Assessment of the associations between three VEGF polymorphisms and risk of prostate cancer.Semantic proximity Read ↗

Associations between vascular endothelial growth factor polymorphisms and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Genetic effects of vascular endothelial growth factor A (VEGF-A) gene mutations and their association with poor clinical characteristics of prostate cancer.Semantic proximity Read ↗

Positive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancer.Semantic proximity Read ↗

Polymorphism of vascular endothelial growth factor -1154G>A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies.Semantic proximity Read ↗

No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population.Semantic proximity Read ↗

Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population.Semantic proximity Read ↗

Association between three genetic variants in kallikrein 3 and prostate cancer riskSemantic proximity Read ↗

Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk.Semantic proximity Read ↗

Association of IL-1β and IL-10 Polymorphisms with Prostate Cancer Risk and Grade of Disease in Eastern Croatian Population.Semantic proximity Read ↗

Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.Semantic proximity Read ↗

Association between the 8473T>C polymorphism of PTGS2 and prostate cancer risk: a metaanalysis including 24,716 subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.